Person-specific biomolecular coronas modulate nanoparticle interactions with immune cells in human blood

Ju, Y; Kelly, HG; Dagley, LF; Reynaldi, A; Schlub, TE; Spall, SK; Bell, CA; Cui, J; Mitchell, AJ; Lin, Z; Wheatley, AK; Thurecht, KJ; Davenport, MP; Webb, AI; Caruso, F; Kent, SJ

Author(s): Ju, Y; Kelly, HG; Dagley, LF; Reynaldi, A; Schlub, TE; Spall, SK; Bell, CA; Cui, J; Mitchell, AJ; Lin, Z; Wheatley, AK; Thurecht, KJ; Davenport, MP; Webb, AI; Caruso, F; Kent, SJ;
Details: Publication Year 2020-10-28,Volume 14,Issue #11,Page 15723-15737
Journal Title: ACS Nano
Publication Type: Journal Article
Abstract: When nanoparticles interact with human blood, a multitude of plasma components adsorb onto the surface of the nanoparticles, forming a biomolecular corona. Corona composition is known to be influenced by the chemical composition of nanoparticles. In contrast, the possible effects of variations in the human blood proteome between healthy individuals on the formation of the corona and its subsequent interactions with immune cells in blood are unknown. Herein, we prepared and examined a matrix of 11 particles (including organic and inorganic particles of three sizes and five surface chemistries) and plasma samples from 23 healthy donors to form donor-specific biomolecular coronas (personalized coronas) and investigated the impact of the personalized coronas on particle interactions with immune cells in human blood. Among the particles examined, poly(ethylene glycol) (PEG)-coated mesoporous silica (MS) particles, irrespective of particle size (800, 450, or 100 nm in diameter), displayed the widest range (up to 60-fold difference) of donor-dependent variance in immune cell association. In contrast, PEG particles (after MS core removal) of 860, 518, or 133 nm in diameter displayed consistent stealth behavior (negligible cell association), irrespective of plasma donor. For comparison, clinically relevant PEGylated doxorubicin-encapsulated liposomes (Doxil) (74 nm in diameter) showed significant variance in association with monocytes and B cells across all plasma donors studied. An in-depth proteomic analysis of each biomolecular corona studied was performed, and the results were compared against the nanoparticle-blood cell association results, with individual variance in the proteome driving differential association with specific immune cell types. We identified key immunoglobulin and complement proteins that explicitly enriched or depleted within the corona and which strongly correlated with the cell association pattern observed across the 23 donors. This study demonstrates how plasma variance in healthy individuals significantly influences the blood immune cell interactions of nanoparticles.
Publisher: ACS
Keywords: complement proteins; human blood assay; immunoglobulin; particle−immune cell interactions; personalized protein corona; proteomics analysis
Research Division(s): Advanced Technology And Biology
PubMed ID: 33112593
Publisher's Version: https://doi.org/10.1021/acsnano.0c06679
Terms of Use/Rights Notice: Refer to copyright notice on published article.

Creation Date: 2021-02-01 12:05:25

Last Modified: 2021-03-02 10:59:52